Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors - Chiu, Chun‐Huei; Wang, Wei‐Yao; Chen, Hung‐Yi; Liao, Pei‐Lun; Jong, Gwo‐Ping; Yang, Tsung‐Yuan (Cancer science, 2024)
Keywords: Adult; Age; Aged; Carcinoma, Renal Cell - drug therapy; Carcinoma, Renal Cell - epidemiology; Cardiovascular disease; Cell cycle; chronic kidney disease; Chronic obstructive pulmonary disease; Codes; Comorbidity; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Epidemiology; Female; Glucose; Humans; Hypertension; Incidence; Kidney cancer; Kidney diseases; Kidney Neoplasms - drug therapy; Male; Middle Aged; Nonsteroidal anti-inflammatory drugs; Original; ORIGINAL ARTICLES; Patients; Population studies; Prescriptions; Proportional Hazards Models; Renal cell carcinoma; Retrospective Studies; Rheumatoid arthritis; Risk Factors; Sensitivity analysis; SGLT2 inhibitor; Sodium; Sodium-Glucose Transporter 2 Inhibitors - adverse effects; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; type 2 DM; chronic kidney disease; renal cell carcinoma; comorbidity; type 2 DM; SGLT2 inhibitor